Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

WEST PHARMACEUTICAL SERVICES, INC.

(WST)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization1 7 26211 12320 94432 512--
Entreprise Value (EV)1 7 26211 12320 94432 51232 51232 512
P/E ratio 35,8x46,8x62,0x50,8x49,0x43,6x
Yield 0,58%0,41%0,23%0,15%0,17%0,18%
Capitalization / Revenue 4,23x6,05x9,76x11,5x10,6x9,99x
EV / Revenue 4,23x6,05x9,76x11,5x10,6x9,99x
EV / EBITDA 20,5x27,8x39,8x37,0x32,9x29,4x
Price to Book 5,29x7,08x11,3x14,2x11,2x9,13x
Nbr of stocks (in thousands) 74 08073 99173 92774 080--
Reference price (USD) 98,0150283439439439
Announcement Date 02/14/201902/13/202002/18/2021---
1 USD in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 1 7171 8402 1472 8213 0673 255
EBITDA1 3544005268789871 105
Operating profit (EBIT)1 249296417755857967
Operating Margin 14,5%16,1%19,4%26,8%27,9%29,7%
Pre-Tax Profit (EBT)1 241292401747838942
Net income1 207242346659681765
Net margin 12,0%13,1%16,1%23,4%22,2%23,5%
EPS2 2,743,214,578,648,9610,1
Dividend per Share2 0,570,610,660,680,730,81
Announcement Date 02/14/201902/13/202002/18/2021---
1 USD in Million
2 USD
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2
Net sales1 671724707710762803
EBITDA1 208240213214238263
Operating profit (EBIT)1 179211183183195221
Operating Margin 26,7%29,2%25,9%25,7%25,7%27,6%
Pre-Tax Profit (EBT)1 175211181180194219
Net income1 151187176145155175
Net margin 22,5%25,9%24,9%20,4%20,4%21,8%
EPS2 1,992,472,311,912,042,30
Dividend per Share ------
Announcement Date 04/29/202107/29/202110/28/2021---
1 USD in Million
2 USD
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt ------
Net Cash position ------
Leverage (Debt / EBITDA) ------
Free Cash Flow1 184241298454540544
ROE (Net Profit / Equities) 15,5%16,3%20,2%30,5%25,2%21,2%
Shareholders' equity1 1 3381 4851 7142 1602 7063 606
ROA (Net Profit / Asset) 11,0%11,2%13,5%21,0%18,5%16,6%
Assets1 1 8762 1602 5683 1453 6884 606
Book Value Per Share2 18,521,225,130,839,148,1
Cash Flow per Share2 3,834,876,2310,410,810,3
Capex1 105126174250267220
Capex / Sales 6,10%6,87%8,12%8,86%8,69%6,74%
Announcement Date 02/14/201902/13/202002/18/2021---
1 USD in Million
2 USD
Key data
Capitalization (USD) 32 512 105 319
Net sales (USD) 2 146 900 000
Number of employees 9 200
Sales / Employee (USD) 233 359
Free-Float 97,8%
Free-Float capitalization (USD) 31 793 749 187
Avg. Exchange 20 sessions (USD) 197 467 166
Average Daily Capital Traded 0,61%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA